Document ID: chunk:federal_register_of_legislation:F2023L01752:schedule:1:p2
Version: federal_register_of_legislation:F2023L01752
Segment Type: schedule
Provision Reference: sch 1 (pt 2/2)
Character Range: 5562–8328

for this condition; AND
                   The treatment must commence within 12 weeks of complete resection; AND
                   Patient must not receive more than 12 months of combined PBS‑subsidised and non‑PBS‑subsidised adjuvant therapy.

       (b)           omit:
   C10695  P10695  Resected Stage IIIB, Stage IIIC or Stage IIID malignant melanoma                                                                                         Compliance with Authority Required procedures
                   Continuing treatment ‑ 3 weekly treatment regimen
                   Patient must have previously been issued with an authority prescription for this drug for adjuvant treatment following complete surgical resection; AND
                   Patient must not have experienced disease recurrence; AND
                   The treatment must be the sole PBS‑subsidised therapy for this condition; AND
                   Patient must not receive more than 12 months of combined PBS‑subsidised and non‑PBS‑subsidised adjuvant therapy.

       (c)           insert in numerical order after existing text:
   C14770  P14770  Stage IIIB, Stage IIIC or Stage IIID malignant melanoma                                                                                             Compliance with Authority Required procedures
                   Initial treatment - 3 weekly treatment regimen
                   The treatment must be in addition to complete surgical resection; AND
                   Patient must have a WHO performance status of 1 or less; AND
                   The treatment must be the sole PBS-subsidised therapy for this condition; AND
                   Patient must not have received prior PBS-subsidised treatment for this condition; AND
                   The treatment must commence within 12 weeks of complete resection; AND
                   Patient must not have received more than 12 months of therapy (irrespective of whether therapy has been partly PBS-subsidised/non-PBS-subsidised).
   C14786  P14786  Resected Stage IIIB, Stage IIIC or Stage IIID malignant melanoma                                                                                    Compliance with Authority Required procedures
                   Continuing treatment - 3 weekly treatment regimen
                   Patient must be undergoing continuing PBS-subsidised treatment commenced through an 'Initial treatment' listing.
                   Patient must not have experienced disease recurrence; AND
                   The treatment must be the sole PBS-subsidised therapy for this condition; AND
                   Patient must not have received more than 12 months of therapy (irrespective of whether therapy has been partly PBS-subsidised/non-PBS-subsidised).